Glutathione-responsive nano-transporter-mediated siRNA delivery: Silencing the mRNA expression of Ras

Protoplasma

Volumn 250, Issue 3, 2013, Pages 787-792

  Doss, C George Priya ^a   Debottam, S ^a   Debajyoti, C ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Glutathione responsive nano transporter; Ras; RNAi; siRNA

Indexed keywords

CARRIER PROTEIN; GLUTATHIONE TRANSPORTER; MESSENGER RNA; RAS PROTEIN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE;

ANIMALS; HUMANS; MEMBRANE TRANSPORT PROTEINS; RAS PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84878017022     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-012-0451-1     Document Type: Article

References (39)

1. Aigner A (2007) Applications of RNA interference: current state and prospects for siRNA based strategies in vivo. Appl Microbiol Biotechnol 76: 9-21.
2. Akhtar S, Benter IF (2007) Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 117: 3623-3632.
3. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V et al (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26: 561-569.
4. Arunachalam B, Phan UT, Geuze HJ, Cresswell P (2000) Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferoninducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA 97: 745-750.
5. Aubry S, Burlina F, Dupont E, Delaroche D, Joliot A, Lavielle S, Chassaing G, Sagan S (2009) Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J 23: 2956-2967.
6. Berger N, Sachse A, Bender J, Schubert R, Brandl M (2001) Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. Int J Pharm 223: 55-68.
7. Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2: 711-719.
8. Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z (2011) Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Contr Release 152: 2-12.
9. Chono S, Li SD, Conwell CC, Huang L (2008) An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J Control 131: 64-69.
10. Collins DS, Unanue ER, Harding CV (1991) Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 147: 4054-4059.
11. de Fougerolles AR (2008) Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 19: 125-132.
12. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6: 443-453.
13. Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP (2004) Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target 12: 257-264.
14. Fattal E, Bochot A (2006) Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv Drug Deliv Rev 58: 1203-1223.
15. Gao K, Huang L (2009) Non-viral methods for siRNA delivery. Mol Pharm 6: 651-658.
16. Guo P (2005) RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy. J Nanosci Nanotechnol 5: 1964-1982.
17. Han SE, Kang H, Shim GY, Suh MS et al (2008) Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int J Pharm 353: 260-269.
18. Higuchi Y, Kawakami S, Fumoto S, Yamashita F et al (2006) Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration. Biol Pharm Bull 29: 1521-1523.
19. Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM et al (2004) Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 165: 2177-2185.
20. Li SD, Huang L (2006) Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm 3: 579-588.
21. Li YL, Zhu L, Liu ZZ, Cheng R, Meng FH, Cui JH, Ji SJ, Zhong Z (2009) Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed 48: 9914-9918.
22. Lu PY, Xie FY, Woodle MC (2005) Modulation of angiogenesis with siRNA inhibitors for novel therapeutics. Trends Mol Med 11: 104-113.
23. Meade BR, Dowdy SF (2008) Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 60: 530-536.
24. Meng FH, Zhong ZY, Feijen J (2009) Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 10: 197-209.
25. Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y et al (2004) Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 32: e109.
26. Oh YK, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61: 850-862.
27. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55: 329-347.
28. Park CW, Chen Z, Kren BT, Steer CJ (2004) Double-stranded siRNA targeted to the huntingtin gene does not induce DNA methylation. Biochem Biophys Res Commun 323: 275-280.
29. Park KM, Kang HC, Cho JK, Chung IJ, Cho SH et al (2009) All-trans-retinoic acid (ATRA)-grafted polymeric gene carriers for nuclear translocation and cell growth control. Biomaterials 30: 2642-2652.
30. Rijcken CJF, Soga O, Hennink WE, van Nostrum CF (2007) Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release 120: 131-148.
31. Schafer FQ, Buettner (2001) GR redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212.
32. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Release 70: 1-20.
33. Sorensen DR, Leirdal M, Sioud M (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 327: 761-766.
34. Takei Y. et al (2004) A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 64: 3365-3370.
35. Torchilin V (2009) Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 71: 431-444.
36. Vashist SK, Zheng D, Pastorin G, Al-Rubeaan K, Luong JHT, Sheu FS (2011) Delivery of drugs and biomolecules using carbon nanotubes. CARBON. 49: 4077-4097.
37. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB (2003) Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. 9: 1291-1300.
38. Yang J, Chen H, Vlahov IR, Cheng JX, Low PS (2006) Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc Natl Acad Sci USA 103: 13872-13877.
39. Zhang J, Wu YO, Xiao L, Li K, Chen LL, Sirois P (2007) Therapeutic potential of RNA interference against cellular targets of HIV infection. Mol. Biotechnol. 37: 225-236.